The Download: whole-body rejuvenation drugs and five things to know about AI

MIT Tech Review highlights dual 2026 AI economy drivers: whole-body rejuvenation drugs entering XPrize competition signal biotech-AI convergence, while "five things to know about AI" underscores rapid advancements. This matters as longevity tech could expand workforce participation, and AI literacy becomes critical for economic competitiveness—reshaping labor markets and healthcare costs in the 2026 landscape.